Verrica Pharmaceuticals Inc
Biotechnology
Healthcare
VRCA
94.84 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.46
52 week high
6.82
high
4.55
52 week low
0.00
low
4.24
growth
-34.80 %
previous Close
4.46
P/E ratio
market cap
61.14 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
283.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top